(Q43593524)

25 November 2017

Impact of depressive symptoms on the treatment of generalized social anxiety disorder (English)

1 reference

25 November 2017

2

1 reference

25 November 2017

3

Edna B Foa

1 reference

25 November 2017

1

Deborah Roth Ledley

1 reference

25 November 2017

Jonathan R T Davidson

series ordinal

4

1 reference

PubMed ID

16175565

25 November 2017

Francis J Keefe

series ordinal

5

1 reference

PubMed ID

16175565

25 November 2017

Nicholas L S Potts

series ordinal

6

1 reference

25 November 2017

1 January 2005

1 reference

25 November 2017

Depression and Anxiety

1 reference

25 November 2017

22

1 reference

25 November 2017

161-167

1 reference

25 November 2017

4

1 reference

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

25 November 2017

1 reference

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

21 January 2018

1 reference

Predictors of response to cognitive-behavioral group therapy for social phobia

21 January 2018

1 reference

7 January 2021

Cognitive therapy versus fluoxetine in generalized social phobia: a randomized placebo-controlled trial

1 reference

7 January 2021

Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia

1 reference

7 January 2021

The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study.

1 reference

7 January 2021

Treatment of social phobia with clonazepam and placebo.

1 reference

7 January 2021

Comorbid anxiety and mood disorders among persons with social anxiety disorder

1 reference

7 January 2021

Context in the clinic: how well do cognitive-behavioral therapies and medications work in combination?

1 reference

7 January 2021

Cognitive behavioral group treatment for social phobia: Comparison with a credible placebo control

1 reference

7 January 2021

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

7 January 2021

Cognitive-behavioral treatment of social phobia: new advances

1 reference

7 January 2021

Study refusal and exclusion from a randomized treatment study of generalized social phobia

1 reference

7 January 2021

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

7 January 2021

Fluoxetine in social phobia: a double-blind, placebo-controlled pilot study

1 reference

7 January 2021

Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms

1 reference

7 January 2021

Moclobemide in social phobia: a controlled dose-response trial

1 reference

7 January 2021

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

1 reference

7 January 2021

Social anxiety disorder and the risk of depression: a prospective community study of adolescents and young adults

1 reference

7 January 2021

Disability and quality of life in social phobia: epidemiologic findings

1 reference

7 January 2021

Relationship of social phobia with other psychiatric illness

1 reference

7 January 2021

Comorbidity among anxiety disorders: implications for treatment and DSM-IV.

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20121

1 reference

25 November 2017

1 reference

PubMed ID

16175565